May. 5 at 1:30 PM
$RNXT Opened a small position at
$0.80. They expect revenue of
$3-4 M this year. Revenue of ~1M will confirm this. However, I feel that any price action on earnings will be suppressed by the selling of shares from the recent S-3.
The ASCO abstract May 24th is what I’m watching. If it looks good, institutions will be looking to load up. In the May 2026 investor presentation they estimate enrolment completion in Q3. It feels like they’ve moved the goalpost a little too far out which has raised my suspicions. They made significant progress with trail enrolment over the last 6 months and they only have 10 or so positions to fill. My guess is they want to announce full enrolment sometime shortly after ASCO. Keep the price low to attract the institutional investors, announce full enrolment to generate hype before finally capitalising on the price action and raising funds. That’s my theory. I’ll be unloading my shares once enrolment is anounced for for a tidy profit (hopefully) ! GLTA
